Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-E Peptide Repertoire and Dimorphism—Centerpieces in the Adaptive NK Cell Puzzle?
Alexander Rölle, Dirk Jäger, Frank Momburg
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axis
Stéphanie Jost, Olivier Lucar, Esther Lee, et al.
Science Immunology (2023) Vol. 8, Iss. 90
Open Access | Times Cited: 29
Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion
Avishai Shemesh, Harry Pickering, Kole T. Roybal, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 8
Open Access | Times Cited: 37
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis
Rachel L. Paterson, Marco Pio La Manna, Victoria Arena De Souza, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Open Access | Times Cited: 7
Dimorphism of HLA-E and Its Disease Association
Leonid M. Kanevskiy, Sofya A. Erokhina, Polina A. Kobyzeva, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5496-5496
Open Access | Times Cited: 47
Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models
David Labib, Zhen Wang, Priya Prakash, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 25
HLA-E–restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD
Hannes Vietzen, Philippe L. Furlano, Jan J. Cornelissen, et al.
Blood (2022) Vol. 141, Iss. 13, pp. 1560-1573
Open Access | Times Cited: 24
Increased risk of late‐onset, immune‐mediated, adverse reactions related to dermal fillers in patients bearing HLA‐B *08 and DRB1 *03 haplotypes
Tom S. Decates, Peter J. Velthuis, Leonie Schelke, et al.
Dermatologic Therapy (2020) Vol. 34, Iss. 1
Open Access | Times Cited: 34
SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity
Nicolas Huot, Philippe Rascle, Caroline Petitdemange, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Role of HLA-G in Viral Infections
Simon Jasinski‐Bergner, Dominik Schmiedel, Ofer Mandelboim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors
Alice Mac Donald, Delphine Guipouy, William Lemieux, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria
Stephen Tukwasibwe, Annettee Nakimuli, James A. Traherne, et al.
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 799-806
Open Access | Times Cited: 30
Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis
Hannes Vietzen, Timo Rückert, Svenja Hartenberger, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 23
Host–virus interaction and viral evasion
Scheilla Teixeira Strumillo, Denis Kartavykh, Fábio Ferreira de Carvalho, et al.
Cell Biology International (2021) Vol. 45, Iss. 6, pp. 1124-1147
Open Access | Times Cited: 22
Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome
Hannes Vietzen, Bernd Döhler, Thuong Hien Tran, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas
Hannes Vietzen, Philipp B. Staber, S. Berger, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Cellular and Molecular Crosstalk of Graft Endothelial Cells During AMR: Effector Functions and Mechanisms
Béatrice Charreau
Transplantation (2021) Vol. 105, Iss. 11, pp. e156-e167
Closed Access | Times Cited: 19
Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis
Hannes Vietzen, Cara Simonitsch, Benjamin Friedel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
Vera Schwane, V. Tran, Sarah Vollmers, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 16
Narrative review of the relationship between the maternal-fetal interface immune tolerance and the onset of preeclampsia
Fangyuan Luo, Jun Yue, Lingling Li, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 12, pp. 713-713
Open Access | Times Cited: 10
HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant
Hana Rohn, Rafael Tomoya Michita, Sabine Schramm, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 847-847
Open Access | Times Cited: 17
Susceptibility of HLA-E*01:03 Allele Carriers to Develop Cytomegalovirus Replication After Living-Donor Kidney Transplantation
Hana Guberina, Fabiola da Silva Nardi, Rafael Tomoya Michita, et al.
The Journal of Infectious Diseases (2017) Vol. 217, Iss. 12, pp. 1918-1922
Open Access | Times Cited: 16
Mechanistic Understanding of EBV+ Lymphoproliferative Disease Development After Transplantation
Philippe L. Furlano, Georg A. Böhmig, Elisabeth Puchhammer‐Stöckl, et al.
Transplantation (2024) Vol. 108, Iss. 9, pp. 1867-1881
Closed Access | Times Cited: 1
Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy
Yan Li, Li Zhu, Yisen Tang, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009934-e009934
Open Access | Times Cited: 1
Natural killer cells and cancer therapy, what we know and where we are going
Faezeh Ghaemdoust, Mahsa Keshavarz‐Fathi, Nima Rezaei
Immunotherapy (2019) Vol. 11, Iss. 14, pp. 1231-1251
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top